Cardiac-specific troponins in uncomplicated pregnancy and pre-eclampsia: A systematic review
Open Access
- 26 February 2021
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2), e0247946
- https://doi.org/10.1371/journal.pone.0247946
Abstract
The risk of myocardial infarction (MI) increases during pregnancy, particularly in women with pre-eclampsia. MI is diagnosed by measuring high blood levels of cardiac-specific troponin (cTn), although this may be elevated in women with pre-eclampsia without MI, which increases diagnostic uncertainty. It is unclear how much cTn is elevated in uncomplicated and complicated pregnancy, which may affect whether the existing reference intervals can be used in pregnant women. Previous reviews have not investigated high-sensitivity troponin in pregnancy, compared to older, less sensitive methods. Electronic searches using the terms “troponin I” or “troponin T”, and “pregnancy”, “pregnancy complications” or “obstetrics”. cTn levels were extracted from studies of women with uncomplicated pregnancies or pre-eclampsia. The search identified ten studies with 1581 women. Eight studies used contemporary methods that may be too insensitive to use reliably in this clinical setting. Two studies used high-sensitivity assays, with one reporting an elevation in troponin I (TnI) in pre-eclampsia compared to uncomplicated pregnancy, and the other only examining women with pre-eclampsia. Seven studies compared cTn between women with pre-eclampsia or uncomplicated pregnancy using any assay. Seven studies showed elevated TnI in pre-eclampsia compared to uncomplicated pregnancy or non-pregnant women. One study measured troponin T (TnT) in pregnancy but did not examine pre-eclampsia. TnI appears to be elevated in pre-eclampsia, irrespective of methodology, which may reflect the role of cardiac stress in this condition. TnI may be similar in healthy pregnant and non-pregnant women, but we found no literature reporting pregnancy-specific reference intervals using high-sensitivity tests. This limits broader application of cTn in pregnancy. There is a need to define reference intervals for cTn in pregnant women, which should involve serial sampling throughout pregnancy, with careful consideration for gestational age and body mass index, which cause dynamic changes in normal maternal physiology.This publication has 36 references indexed in Scilit:
- High sensitivity cardiac troponin assays in the clinical laboratoriescclm, 2015
- Relationship Between High-Sensitivity Cardiac Troponin I and Blood Pressure Among Young and Healthy AdultsAmerican Journal of Hypertension, 2014
- Morphological and Functional Adaptation of the Maternal Heart During PregnancyCirculation: Cardiovascular Imaging, 2012
- GRADE guidelines: 3. Rating the quality of evidenceJournal of Clinical Epidemiology, 2011
- Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkersJournal of Hypertension, 2009
- Cardiac troponin levels in pregnant women with severe pre-eclampsiaJournal of Obstetrics and Gynaecology, 2009
- Acute Myocardial Infarction in PregnancyCirculation, 2006
- The effect of magnesium sulfate treatment on serum cardiac troponin I levels in preeclamptic womenActa Obstetricia et Gynecologica Scandinavica, 2005
- Cardiac-specific troponin-l radioimmunoassay in the diagnosis of acute myocardial infarctionAmerican Heart Journal, 1987